<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04821245</url>
  </required_header>
  <id_info>
    <org_study_id>BRI IRB18-008</org_study_id>
    <nct_id>NCT04821245</nct_id>
  </id_info>
  <brief_title>Defining Normal Postoperative Magnetic Resonance Imaging After Total Knee Arthroplasty</brief_title>
  <official_title>Defining Normal Postoperative Magnetic Resonance Imaging and Muscle Enzyme Levels After Total Knee Arthroplasty Associated With Continuous Adductor Canal Block</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Benaroya Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Washington State Society of Anesthesiologists</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Benaroya Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study was to describe the postoperative &quot;baseline&quot; magnetic resonance imaging&#xD;
      (MRI) appearance of the ipsilateral thigh musculature after total knee arthroplasty (TKA).&#xD;
      The secondary aim was to describe baseline muscle enzyme levels under the same clinical&#xD;
      scenario. Neither of these measures have been reported previously.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  In 2016, 3 sentinel cases of presumed local anesthetic-induced myotoxicity were reported&#xD;
           after TKA with associated continuous adductor canal block (CACB) analgesia. The&#xD;
           diagnosis was made based on its consistency with animal and human descriptions of local&#xD;
           anesthetic myotoxicity, including: a) exposure to local anesthetic, b) delayed symptom&#xD;
           onset after a period of normal recovery, c) rapid development of profound muscle&#xD;
           flaccidity, and d) complete to partial recovery of motor function after weeks to months.&#xD;
           MRIs obtained in these patients showed diffuse intra- and inter-muscular edema&#xD;
           (inflammation) of the ipsilateral thigh, which was believed to support the presumptive&#xD;
           diagnosis. However, because baseline MRI appearance of upper leg muscles has never been&#xD;
           described for this clinical scenario, it is possible that the MRI scans represented&#xD;
           &quot;normal, baseline&quot; appearance.&#xD;
&#xD;
        -  This case series intended to prospectively describe postoperative MRI appearance in a&#xD;
           cohort of asymptomatic volunteer patients that underwent uncomplicated TKA/CACB. In&#xD;
           addition, because obtaining biomarkers of muscle injury might also be a reasonable&#xD;
           diagnostic step, we sought to measure preoperative and postoperative creatine&#xD;
           phosphokinase (CPK) and aldolase levels.&#xD;
&#xD;
        -  MRI scans were read by 5 board-certified musculoskeletal radiologists masked to the&#xD;
           study's purpose. Grading was done using a standard grid that facilitated systematic&#xD;
           evaluation of various regions within the upper leg. At least 3 of 5 radiologists were&#xD;
           required to declare edema as present within a given region of the leg.&#xD;
&#xD;
        -  Only those volunteer patients that presented a normal postoperative course, i.e., had no&#xD;
           unexpected leg muscle weakness, were entered into the study. As such, the MRI and muscle&#xD;
           enzyme analysis results had no impact on the volunteer patients' clinical outcome or&#xD;
           management. This was a prospective, observational/descriptive case series. There was no&#xD;
           control group and we did not intend to investigate issues of cause-and-effect.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 4, 2018</start_date>
  <completion_date type="Actual">August 2, 2019</completion_date>
  <primary_completion_date type="Actual">August 2, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Edema</measure>
    <time_frame>1-2 days postoperative</time_frame>
    <description>Regions of the ipsilateral thigh were defined by muscle group, neuromuscular bundle, subcutaneous tissue, or inter-muscular fascial layers. Five board-certified musculoskeletal radiologists analyzed the scans for presence of edema. Edema was considered present if judged to be so by at least 3 of the 5 radiologists.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative Muscle Enzyme Levels</measure>
    <time_frame>Sample was drawn the morning after surgery</time_frame>
    <description>Participants with Postoperative Creatine Phosphokinase (CPK) or Aldolase levels above the upper limit of normal</description>
  </secondary_outcome>
  <enrollment type="Actual">36</enrollment>
  <condition>Local Anesthetic Complication</condition>
  <condition>Local Anesthetic Drug Adverse Reaction</condition>
  <eligibility>
    <study_pop>
      <textblock>
        -  Volunteer patients of various age and sex&#xD;
&#xD;
          -  Number of volunteers and diagnostic studies determined by available grant monies&#xD;
&#xD;
          -  Volunteers were drawn from a population presenting for unilateral primary TKA&#xD;
             performed by 1 of 2 orthopedic surgeons in a single institution&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Scheduled for unilateral primary TKA with CACB&#xD;
&#xD;
          -  TKA and early recovery was uncomplicated (no evidence of unexpected leg weakness)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindication to spinal anesthesia or adductor canal-based analgesia&#xD;
&#xD;
          -  History of muscle wasting or related disease&#xD;
&#xD;
          -  History of autoimmune disorders that may affect muscles&#xD;
&#xD;
          -  History of neurologic condition affecting the lower extremities&#xD;
&#xD;
          -  Contraindications to MRI&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph M Neal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Benaroya Research Center at Virginia Mason Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Benaroya Research Institute</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Neal JM, Salinas FV, Choi DS. Local Anesthetic-Induced Myotoxicity After Continuous Adductor Canal Block. Reg Anesth Pain Med. 2016 Nov/Dec;41(6):723-727.</citation>
    <PMID>27662067</PMID>
  </reference>
  <reference>
    <citation>Neal JM, Salinas FV, Choi DS. Reply to Dr Kelly et al. Reg Anesth Pain Med. 2017 May/Jun;42(3):414. doi: 10.1097/AAP.0000000000000574.</citation>
    <PMID>28419048</PMID>
  </reference>
  <reference>
    <citation>Hussain N, McCartney CJL, Neal JM, Chippor J, Banfield L, Abdallah FW. Local anaesthetic-induced myotoxicity in regional anaesthesia: a systematic review and empirical analysis. Br J Anaesth. 2018 Oct;121(4):822-841. doi: 10.1016/j.bja.2018.05.076. Epub 2018 Aug 8.</citation>
    <PMID>30236244</PMID>
  </reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>March 25, 2021</study_first_submitted>
  <study_first_submitted_qc>March 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2021</study_first_posted>
  <results_first_submitted>March 28, 2021</results_first_submitted>
  <results_first_submitted_qc>May 3, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">May 25, 2021</results_first_posted>
  <last_update_submitted>May 3, 2021</last_update_submitted>
  <last_update_submitted_qc>May 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Benaroya Research Institute</investigator_affiliation>
    <investigator_full_name>Joseph M. Neal</investigator_full_name>
    <investigator_title>Affiliate Investigator</investigator_title>
  </responsible_party>
  <keyword>Myotoxicity</keyword>
  <keyword>Myositis</keyword>
  <keyword>Magnetic resonance imaging</keyword>
  <keyword>Creatine phosphokinase</keyword>
  <keyword>Aldolase</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Drug-Related Side Effects and Adverse Reactions</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>De-identified raw data in Excel format may be obtained from Joseph M. Neal, MD upon request.</ipd_description>
    <ipd_time_frame>March 2021 through March 2026</ipd_time_frame>
    <ipd_access_criteria>Upon request</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan: w/o statistical comment</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 13, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/45/NCT04821245/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan: Statistical Analysis Plan (specific comment)</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 9, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/45/NCT04821245/SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>April 25, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/45/NCT04821245/ICF_002.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Tertiary care medical center&#xD;
December 2018 through August 2019&#xD;
Potential volunteers were contacted by the principal investigator at least 24 hours prior to their surgery. Informed consent was obtained at this point.&#xD;
Volunteers could decline to proceed at any point from initial informed consent through MRI scan or final blood draw</recruitment_details>
      <pre_assignment_details>-Volunteer patients only entered the study if they showed no signs of unexpected ipsilateral upper leg weakness prior to drawing blood samples or obtaining MRI scans</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Single Cohort</title>
          <description>All volunteer patients</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Overall Study</title>
          <description>All enrolled subjects</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="27"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="27"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62" lower_limit="46" upper_limit="75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="27"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="27"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="89" lower_limit="59" upper_limit="134"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Edema</title>
        <description>Regions of the ipsilateral thigh were defined by muscle group, neuromuscular bundle, subcutaneous tissue, or inter-muscular fascial layers. Five board-certified musculoskeletal radiologists analyzed the scans for presence of edema. Edema was considered present if judged to be so by at least 3 of the 5 radiologists.</description>
        <time_frame>1-2 days postoperative</time_frame>
        <population>Participants that underwent postoperative MRI scan of operated leg</population>
        <group_list>
          <group group_id="O1">
            <title>Participants Undergoing MRI</title>
            <description>Number of Participants with Edema</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Edema</title>
          <description>Regions of the ipsilateral thigh were defined by muscle group, neuromuscular bundle, subcutaneous tissue, or inter-muscular fascial layers. Five board-certified musculoskeletal radiologists analyzed the scans for presence of edema. Edema was considered present if judged to be so by at least 3 of the 5 radiologists.</description>
          <population>Participants that underwent postoperative MRI scan of operated leg</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Muscle Enzyme Levels</title>
        <description>Participants with Postoperative Creatine Phosphokinase (CPK) or Aldolase levels above the upper limit of normal</description>
        <time_frame>Sample was drawn the morning after surgery</time_frame>
        <population>Participants with CPK levels 12% to 111%, and aldolase levels, in excess of high normal values</population>
        <group_list>
          <group group_id="O1">
            <title>CPK Analysis</title>
            <description>CPK Levels Above High Normal</description>
          </group>
          <group group_id="O2">
            <title>Aldolase Analysis</title>
            <description>Aldolase Levels Above High Normal</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Muscle Enzyme Levels</title>
          <description>Participants with Postoperative Creatine Phosphokinase (CPK) or Aldolase levels above the upper limit of normal</description>
          <population>Participants with CPK levels 12% to 111%, and aldolase levels, in excess of high normal values</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>10 days. Participant was evaluated at the time of the incident and twice during the 10 days thereafter.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>MRI Appearance</title>
          <description>Volunteers undergoing MRI examination</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Warmth around adductor canal catheter during MRI</sub_title>
                <description>As described above - mild, vague warmth around catheter at start of MRI, which was subsequently cancelled. The warmth resolved quickly and the patient was not harmed.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>This case series aimed to describe MRI appearance and muscle enzyme levels presented under the same clinical conditions as the 3 sentinel cases of presumed local anesthetic myotoxicity after TKA/CACB. This descriptive design was not intended to sort cause-and-effect (that is, the relative role of surgery, pneumatic tourniquet, local anesthetic, etc.) in causing muscular edema or raising enzyme levels.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Joseph M. Neal, MD</name_or_title>
      <organization>Benaroya Research Institute</organization>
      <phone>206-223-6980</phone>
      <email>Joseph.Neal@virginiamason.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

